10x Genomics, Inc. (TXG)

10x Genomics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,999	6,615	4,171	16,640	15,237	7,333
Market Cap Growth	-30.51%	58.59%	-74.93%	9.21%	107.79%	-
Enterprise Value	1,719	6,322	3,829	16,126	14,611	6,886
PE Ratio	-	-25.93	-25.13	-285.80	-28.07	-234.65
PS Ratio	3.20	10.69	8.08	33.92	50.99	29.82
PB Ratio	2.78	8.93	5.18	20.35	20.62	17.46
P/FCF Ratio	-60.64	-103.69	-25.24	-135.67	-59.86	-903.63
P/OCF Ratio	-166.90	-435.28	-124.12	-778.55	-69.93	211.77
EV/Sales Ratio	2.75	10.22	7.41	32.88	48.89	28.00
EV/EBITDA Ratio	-19.93	-30.82	-29.80	-655.66	-28.44	-329.67
EV/EBIT Ratio	-16.32	-25.42	-23.71	-305.13	-27.42	-246.34
EV/FCF Ratio	-56.85	-99.09	-23.17	-131.48	-57.40	-848.57
Debt / Equity Ratio	0.13	0.13	0.12	0.10	0.09	0.07
Debt / EBITDA Ratio	-0.44	-0.46	-0.74	-3.33	-0.12	-1.42
Debt / FCF Ratio	-1.25	-1.49	-0.58	-0.67	-0.25	-3.66
Quick Ratio	4.26	3.96	4.14	6.17	6.26	8.09
Current Ratio	5.22	4.69	4.85	6.77	6.56	7.63
Asset Turnover	0.65	0.63	0.51	0.50	0.38	0.67
Interest Coverage	-17126.47	-7537.27	-339.28	-61.03	-316.76	-9.08
Return on Equity (ROE)	-35.30%	-33.10%	-20.90%	-7.40%	-91.80%	-31.20%
Return on Assets (ROA)	-27.60%	-26.00%	-16.50%	-5.90%	-68.60%	-8.60%
Return on Capital (ROIC)	-33.89%	-31.72%	-18.64%	-5.81%	-66.60%	-6.80%
Earnings Yield	-13.22%	-3.86%	-3.98%	-0.35%	-3.56%	-0.43%
FCF Yield	-3.69%	-0.96%	-3.96%	-0.74%	-1.67%	-0.11%
Buyback Yield / Dilution	-3.26%	-2.90%	-3.18%	-9.09%	-158.76%	-191.89%
Total Shareholder Return	-3.26%	-2.90%	-3.18%	-9.09%	-158.76%	-191.89%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).